No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa
USA — Pharmaceutical company Bristol-Myers Squibb (BMS) has once again expanded its collaboration with Evotec, a drug discovery and development company. BMS has paid another US$50 million upfront to deepen…
Read More
GERMANY — Bristol Myers Squibb, following its European approval last September, has announced that it will not be launching Opdualag, an infusion of Opdivo and new antibody relatlimab, in Germany…
Read More
UNITED KINGDOM – Bristol Myers Squibb has acquired Turning Point Therapeutics in a US$4.1 billion deal and a new cancer asset slated to hit the markets next year, setting in…
Read More
USA – Bristol-Myers Squibb (BMS) announced that the first drug in a new class of cancer immunotherapies has been approved by US FDA as an initial treatment for advanced melanoma,…
Read More
USA – Teva has launched its generic version of Bristol Myers Squibb’s Revlimid (lenalidomide) in the United States on Monday, making it the country’s first generic version of the cancer…
Read More
USA – Eli Lilly and Company has announced a drug discovery collaboration with Evotec in the field of metabolic diseases, with a focus on kidney diseases and diabetes. The three-year…
Read More
USA – The US Food and Drug Administration (FDA) has given Orencia approval as a preventative therapy for acute graft-versus-host disease (GVHD) in combination with certain immunosuppressants. Orencia is the…
Read More
USA – The Food and Drug Administration (FDA) has added strictest warnings to the labels of JAK inhibitors, a class of drugs used to treat arthritis manufactured by Pfizer, Eli…
Read More